Full data view for gene TSC2

The curator’s expert opinion on the classification of a variant, can be found in the
SUMMARY record. Regarding the classification, please note that where there are several
records of the same variant, the classification of that variant may differ depending on the
submitter’s conclusion.
Information The variants shown are described using the NM_000548.3 transcript reference sequence.

7 entries on 1 page. Showing entries 1 - 7.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
-/. - c.4316G>A r.(?) p.(Gly1439Asp) - - Unknown - benign g.2134539G>A g.2084538G>A TSC2(NM_000548.3):c.4316G>A (p.G1439D) - TSC2_002007 VKGL data sharing initiative Nederland - - - CLASSIFICATION record - - - - - - - - - - - - - - - - - - - - - - -
-?/. 34 c.4316G>A - p.Gly1439Asp - - Unknown - NA g.2134539G>A g.2084538G>A - - TSC2_002007 S6K T389 phosphorylation not significantly higher than wild type TSC2, but is significantly lower than pathogenic TSC variant PubMed: Hoogeveen-Westerveld, 2011 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
-?/. 34 c.4316G>A r.(?) p.(Gly1439Asp) - - Unknown - likely benign g.2134539G>A g.2084538G>A 4265G>A, (p.G1439D/G1416D) - TSC2_002007 - PubMed: Coevoets, 2009, PubMed: Hoogeveen-Westerveld, 2011 - - Germline - - -Cac8I - - DNA SEQ Blood - TSC - PubMed: Coevoets, 2009, PubMed: Hoogeveen-Westerveld, 2011 - ? - - - - - - - 1 Rosemary Ekong
?/. 34 c.4316G>A r.(?) p.(Gly1439Asp) - - Unknown - VUS g.2134539G>A g.2084538G>A - - TSC2_002007 found with TSC2 missense c.3986G>A; complete screen, MLPA kits P124 (TSC1) & P046B2 (TSC2) used unpublished - rs150397923 Germline - - -Cac8I - - DNA SEQ, MLPA Blood - TSC - unpublished no known FH of TS; patient has two TSC2 missense variants c.3986G>A and c.4316G>A; no other potentially pathogenic variant found; both variants absent in the one parent tested; other parent unavailable for testing M - - - - - - - 1 Rosemary Ekong
-?/. 34 c.4316G>A r.(?) p.(Gly1439Asp) - - Maternal (confirmed) - likely benign g.2134539G>A g.2084538G>A - - TSC2_002007 found with two TSC2 missense variants c.3206T>A and c.5321G>C; complete screen with MLPA and SEQ unpublished - - Germline - - -Cac8I - - DNA SEQ, MLPA Blood - TSC - unpublished patient has 3 TSC2 missense variants (TSC2 c.3206T>A, c.4316G>A and c.5321G>C); both apparently unaffected parents tested; TSC2 missense c.3206T>A absent in both parents, but the other two TSC2 missense variants (c.4316G>A and c.5321G>C) present in one parent and both absent in the other parent; referred for diagnostic TS testing F - - - - - - - 1 Rosemary Ekong
-/. 34 c.4316G>A r.(?) p.(Gly1439Asp) - - Unknown - likely benign g.2134539G>A - exon 33 - TSC2_002007 found with TSC2 exons 2-9 deletion, TSC1 silent c.1977G>A, TSC2 c.1258-32dup, TSC2 silent c.4908C>T and TSC2 missense c.5321G>C unpublished - - Germline ? - - - - DNA DHPLC, MLPA, SEQ Blood Diagnostic testing, MLPA (All exons for TSC1 and TSC2, exons 40 and 46 only for PKD1) TSC - unpublished prenatally detected cardiac rhabdomyomas on USS and brain lesions on fetal MRI; No other family member tested F ? - - - - - - 1 Rosemary Ekong
-/- 34 c.4316G>A r.(?) p.(Gly1439Asp) - - Unknown - benign g.2134539G>A g.2084538G>A - - TSC2_002007 - - - rs150397923 SUMMARY record - 657/143354 alleles, 7 homozygotes Hpy188III+, Cac8I- - - - - - - - - - - - - - - - - - - - -
Legend   How to query  

Assessment of functional consequences - Our conclusions on the functional consequences of variants are based on the type of variant, results of in vitro functional tests (doi: 10.1002/humu.21451; doi: 10.1002/humu.22202; doi: 10.1002/humu.23963), population frequencies, output from in silico splice site prediction algorithms, and any clinical/family data available to us. We also have output from protein prediction programs in this database for comparison purposes and they are not considered in our assessment of pathogenicity. PolyPhen Predictions - Note that these results are from PolyPhen-2 and only the HumDiv classification is shown.


Screenscraping/webscraping (interacting with LOVD using scripts to download data) is strictly prohibited.
Use our APIs to retrieve data.